Clinical efficacy evaluation of tyrosine kinase inhibitors for non-adenocarcinoma lung cancer patients harboring EGFR-sensitizing mutations

Clinical efficacy evaluation of tyrosine kinase inhibitors for non-adenocarcinoma lung cancer patients harboring EGFR-sensitizing mutations

Xinyu Song,1 Zhehai Wang2 1School of Medicine and Life Sciences, University of Jinan-Shandong Academy of Medical Sciences, 2Shandong Cancer Hospital Affiliated to Shandong University, Jinan, Shandong, People’s Republic of China Abstract: Epidermal growth factor receptor (EGFR) tyrosine k...

Full description

Bibliographic Details
Main Authors: Song X, Wang Z
Format: Article
Language:English
Published: Dove Medical Press 2017-06-01
Series:OncoTargets and Therapy
Subjects:
EGFR mutation
Tyrosine kinase inhibitors
Non-adenocarcinoma
Online Access:https://www.dovepress.com/clinical-efficacy-evaluation-of-tyrosine-kinase-inhibitors-for-non-ade-peer-reviewed-article-OTT

Internet

https://www.dovepress.com/clinical-efficacy-evaluation-of-tyrosine-kinase-inhibitors-for-non-ade-peer-reviewed-article-OTT

Similar Items